Comments*

 
  • Neuroscience

  • Related Publications

    eBriefing

    Alzheimer's Disease as a Neurovascular Inflammatory Disorder

    Keynote Speaker: Costantino Iadecola (Weill Cornell Medicine)

    This eBriefing covers the basic research and clinical science elucidating such mechanisms that underlie the contribution of inflammatory pathways to vascular cognitive impairment and dementia.

    eBriefing

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speakers: Barry G. Arnason, MD (University of Chicago) and Giancarlo Comi, MD (Università Vita-Salute San Raffaele)

    This one-day, translational conference brought together academic and clinical researchers with industry leaders to discuss current therapeutics.

    eBriefing

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute, MIT)

    MicroRNAs (miRNA) play critical roles in regulating gene expression. This symposium presented up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff.

    This diverse collection of papers discusses topics ranging from a paleobiologic study of the emergence of the diaphragm to changes in gait patterns after acute brain injury.

    eBriefing

    Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Featuring: Sharon Inouye (Harvard Medical School)

    Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia for many patients, a risk that is poorly understood and often under-recognized in the clinic. With numerous factors—including age—contributing to each patient's level of risk, what are the challenges and opportunities to creating biomarkers and therapeutics for those who are most vulnerable?

    Annals

    Special Issue: From Knowledge to Wisdom: Science and the Good Life

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents papers from a three-part series, in collaboration with the Nour Foundation, on the science of happiness, morality, and wisdom.

    Volume 1384

    Annals

    Special Issue: Countermeasures Against Chemical Threats II

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Discussions of various countermeasures to chemical threats.

    Annals

    Special Issue: Beyond the IQ Test

    Edited by Frank C. Worrell (University of California, Berkeley), Ronald A. Beghetto (University of Connecticut), and Joseph Renzulli (University of Connecticut)

    Discussions of the latest research on innovative approaches to fostering the development of gifted/talented children.

    eBriefing

    Disease Drivers of Aging: The 2016 Advances in Geroscience Summit

    Keynote Speakers: Richard Hodes (National Institute on Aging, NIH), Felipe Sierra (National Institute on Aging, NIH), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)

    This eBriefing looks at how chronic diseases—specifically HIV/AIDS, diabetes, and cancer—affect aging, with a focus on the seven mechanistic pillars of aging.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.

    Volume 1375